Thymosin Alpha 1 in the Prevention of Pancreatic Infection Following Acute Necrotizing Pancreatitis
Clinical trial NCT02473406 · COMPLETED
Trial details
- NCT number
- NCT02473406
- Sponsor
- Weiqin Li
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-27
- Primary completion
- 2020-12-24
- Enrollment
- 508
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.